Clinical Trials Directory

Trials / Unknown

UnknownNCT01593865

The Catholic University BIMA Grafting Study

Observational, Case-Control, Propensity-Matched Study of Bilateral Versus Monolateral Internal Mammary Artery Grafting for Severe Coronary Artery Disease. Assessment of Feasibility of Systematic Bilateral Mammary Artery Grafting and Early/Late Clinical Outcomes

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Catholic University, Italy · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The present study hypothesizes that the systematic use of bilateral internal mammary artery (BIMA) grafting is feasible in the practice of a University Cardiac Surgery Institution for the treatment of multivessel coronary artery disease (primary hypothesis). The secondary study hypothesis is that the BIMA grafting meets the safety endpoint compared with the conventional surgical strategy entailing left mammary artery grafting plus great saphenous vein grafts to revascularize the remaining coronary targets. The tertiary study hypothesis is that the BIMA grafting yields better follow-up results in terms of recurrence of symptoms related to coronary disease, of repeat revascularization and of cardiac mortality compared with patients treated with the conventional surgical strategy entailing left mammary artery grafting plus great saphenous vein grafts to revascularize the remaining coronary targets.

Conditions

Interventions

TypeNameDescription
PROCEDUREBIMA GraftingBoth the left and the right internal mammary arteries are harvested and used to revascularize the two major coronary targets. Further coronary targets may be revascularized using either great saphenous vein or radial artery grafts, if present.
PROCEDURELeft-only mammary artery graftingThese patients had only the left mammary artery harvested and used to revascularize the major coronary target. Great saphenous vein grafts and/or radial artery grafts were employed to revascularize the remaining targets.

Timeline

Start date
2012-04-01
Primary completion
2014-06-01
First posted
2012-05-08
Last updated
2012-08-21

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT01593865. Inclusion in this directory is not an endorsement.